Carallia brachiata
Carallia brachiata · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Carallia brachiata is a significant medicinal plant known for its diverse therapeutic applications in traditional healing practices. The stem of this species is particularly valued for its potent bioactive properties. It is frequently utilized in natural remedies to help manage and alleviate symptoms of fever. Additionally, the plant plays a crucial role in promoting effective wound healing through its restorative qualities. Understanding its botanical characteristics provides insight into its importance in herbal medicine.
- Synonyms
- Eugenia Cupulifera · Carallia Confinis · 44 more
- Common names
- Not available
- Family
- Rhizophoraceae
- Distribution
- Not available
- Plant Parts
- Stem
Classification
Common Names
Carallia brachiata is a versatile botanical species known by a diverse array of regional names. Frequently referred to as the billabong-tree, it plays a vital role in its specific aquatic ecosystems. It is also commonly called the freshwater mangrove, reflecting its unique ability to thrive in such environments. In different areas, locals may simply call it Carallia or identify it as carallawood. Additionally, the plant is recognized as corkybark due to the distinct texture of its exterior.
Sources: Catalogue of Life (COL)
Synonyms
Carallia brachiata is a botanical species that has been documented under several different scientific names throughout history. It is frequently identified by the synonyms Baraultia madagascariensis and Barraldeia madagascariensis in various taxonomic records. The plant is also linked to the name Bruguiera nemorosa, reflecting shifts in its historical classification. Furthermore, researchers have previously referred to this species as Carallia arguta in earlier studies. Finally, the name Carallia baraldeia serves as another recognized synonym for this specific plant.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Carallia brachiata is a distinctive species belonging to the vast kingdom Plantae. Within this expansive biological realm, it is classified under the class Equisetopsida. This plant further falls into the order Malpighiales, showcasing its evolutionary connections. It is specifically categorized under the genus Carallia, which defines its unique botanical traits. Finally, its taxonomic identity is completed by its placement within the family Rhizophoraceae.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Malpighiales |
| Family | Rhizophoraceae |
| Genus | Carallia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Carallia brachiata is a versatile species with a wide-ranging distribution across several diverse geographic regions. In Africa, its presence extends through the Western Indian Ocean and into Madagascar. The plant also flourishes across various parts of Asia, including the temperate regions of China, specifically within its South-Central and Southeast territories as well as Hainan. Furthermore, it can be found within the tropical landscapes of the Indian Subcontinent, notably in Assam. This broad range highlights the plant's ability to adapt to multiple distinct ecosystems.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Carallia brachiata is a self-supporting tree that plays a significant role in its natural ecosystem. This botanical species exhibits a versatile growth form, allowing it to establish a sturdy presence in the forest. While its stature can vary, it is known to reach a minimum height of 3 meters. For many specimens, the growth typically stabilizes at a minimum of 11.75 meters. However, in ideal conditions, this impressive tree can attain a maximum height of 33 meters.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Carallia brachiata contains medicinal lignans that serve as effective agents for treating chronic inflammation. By inhibiting specific inflammatory mediators, the plant also shows potential in the treatment of degenerative diseases. These bioactive compounds can address systemic issues such as fever by modulating macrophage activation. Furthermore, the plant's anti-inflammatory properties help mitigate conditions that would otherwise retard wound healing. Consequently, Carallia brachiata represents a viable source for therapies targeting these diverse medical concerns.
Preparations
Parts used
Carallia brachiata is a medicinal terrestrial plant belonging to the Rhizophoraceae family that holds significant pharmacological potential. Researchers have focused on this species to identify bioactive molecules capable of combating chronic inflammation and degenerative diseases. Specifically, furofuran lignans known as 7'',8''-buddlenol D epimers were successfully isolated from the plant's stem and bark. These compounds demonstrate a strong ability to inhibit nitric oxide and prostaglandin E2 production in cellular models. By suppressing the p38 MAPK signaling pathway, these stem-derived lignans represent promising candidates for future anti-inflammatory therapies.